Treatment of Graves' disease with methimazole in children alters the proliferation of Treg cells and CD3+ T lymphocytes.

Klatka, Maria; Kaszubowska, Lucyna; Grywalska, Ewelina; Wasiak, Magdalena; Szewczyk, Leszek; Foerster, Jerzy; Cyman, Marta; Rolinski, Jacek

Klatka, Maria; Kaszubowska, Lucyna; Grywalska, Ewelina; Wasiak, Magdalena; Szewczyk, Leszek; Foerster, Jerzy; Cyman, Marta; Rolinski, Jacek.

Affiliation

Grywalska E; Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, Lublin, Poland. ewelina.grywalska@gmail.com.

Folia Histochem Cytobiol ; 52(1): 69-77, 2014.

Article in En | MEDLINE | ID: mdl-24802963

Subject(s)

Antithyroid Agents/therapeutic use; Cell Proliferation/drug effects; Graves Disease/drug therapy; Graves Disease/immunology; Methimazole/therapeutic use; T-Lymphocytes, Regulatory/drug effects; T-Lymphocytes/drug effects; Adolescent; CD3 Complex/metabolism; Case-Control Studies; Cells, Cultured; Child; Female; Humans; Lymphocyte Count; T-Lymphocytes/physiology; T-Lymphocytes, Regulatory/physiology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antithyroid Agents / T-Lymphocytes / Graves Disease / T-Lymphocytes, Regulatory / Cell Proliferation / Methimazole Type of study: Observational_studies Limits: Adolescent / Child / Female / Humans Language: En Journal: Folia Histochem Cytobiol Journal subject: HISTOCITOQUIMICA Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google